Company Profile

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE2649.00-10.7 (-0.4 % )
PREV CLOSE (Rs.) 2659.70
OPEN PRICE (Rs.) 2648.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 6635
TODAY'S LOW / HIGH (Rs.)2558.60 2676.65
52 WK LOW / HIGH (Rs.)1554.65 3040
NSE2650.25 -10.7 (-0.4 % )
PREV CLOSE(Rs.) 2660.95
OPEN PRICE (Rs.) 2646.00
BID PRICE (QTY) 2650.25 (624 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 500856
TODAY'S LOW / HIGH(Rs.) 2455.00 2678.35
52 WK LOW / HIGH (Rs.)1555 3031.2

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.21
TTM EPS (Rs.) 59.93
P/E Ratio 44.20
Book Value (Rs.) 320.25
Face Value (Rs.) 5
MCap (Rs. in Mn) 448233.90
Price/Earning (TTM) 27.63
Price/Sales (TTM) 7.29
Price/Book (MRQ) 8.27
PAT Margin (%) 15.00
ROCE (%) 14.68
Incorporation Year : 1972

Management Info :

Samir Mehta - Chairman - Managing Director

Registered Office :

Address : Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone : 079-26599000

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
26Jun06-26-2020$Torrent Pharmaceuticals redeems NCDs of Rs 83 crore Torrent Pharmaceuticals rede

Torrent Pharmaceuticals has been redeemed Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 83 crore and repaid by the Company on June 24, 2020.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharmaceuticals has been redeemed Secured Redeemable No..
18May05-18-2020$Torrent Pharmaceuticals trades in green despite weakness over Dalal Street Torrent Pharmaceuticals trad
Torrent Pharmaceuticals is currently trading at Rs. 2505.90, up by 43.00 points or 1.75% from its previous closing of Rs. 2462.90 on the BSE.

The scrip opened at Rs. 2470.00 and has touched a high and low of Rs. 2528.50 and Rs. 2470.00 respectively. So far 11232 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2679.45 on 09-Apr-2020 and a 52 week low of Rs. 1453.00 on 23-Jul-2019.

Last one week high and low of the scrip stood at Rs. 2528.50 and Rs. 2359.70 respectively. The current market cap of the company is Rs. 42172.74 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 20.80% and 7.95% respectively.

Torrent Pharmaceuticals has raised funds worth Rs 200 crore through issue of Non-Convertible Debentures (NCDs) on Private Placement basis on May 14, 2020. The tenure of the instrument is 1072 days and will mature on April 21, 2023.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharmaceuticals is currently trading at Rs. 2505.90, up..
15May05-15-2020$Torrent Pharmaceuticals raises funds worth Rs 200 crore via NCDs Torrent Pharmaceuticals rais

Torrent Pharmaceuticals has raised funds worth Rs 200 crore through issue of Non-Convertible Debentures (NCDs) on Private Placement basis on May 14, 2020. The tenure of the instrument is 1072 days and will mature on April 21, 2023.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharmaceuticals has raised funds worth Rs 200 crore thr..
15May05-15-2020$Torrent Pharmaceuticals gains on raising funds worth Rs 200 crore via NCDs Torrent Pharmaceuticals gain
Torrent Pharmaceuticals is currently trading at Rs. 2433.55, up by 24.75 points or 1.03% from its previous closing of Rs. 2408.80 on the BSE.

The scrip opened at Rs. 2450.00 and has touched a high and low of Rs. 2450.00 and Rs. 2423.60 respectively. So far 2342 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2679.45 on 09-Apr-2020 and a 52 week low of Rs. 1453.00 on 23-Jul-2019.

Last one week high and low of the scrip stood at Rs. 2525.00 and Rs. 2359.70 respectively. The current market cap of the company is Rs. 41230.24 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 20.80% and 7.95% respectively.

Torrent Pharmaceuticals has raised funds worth Rs 200 crore through issue of Non-Convertible Debentures (NCDs) on Private Placement basis on May 14, 2020. The tenure of the instrument is 1072 days and will mature on April 21, 2023.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
Torrent Pharmaceuticals is currently trading at Rs. 2433.55, up..
15May05-15-2020$Unichem Laboratories, Ircon International and Ashok Leyland to see some action today Unichem Laboratories, Ircon

Unichem Laboratories has received the Establishment Inspection Report (EIR) from United Stated Food and Drug Administration (USFDA) on May 13, 2020 for its Active Pharmaceutical Ingredients (APIs) facility at Roha. The USFDA conducted the inspection of its Roha facility from February 17, 2020 to February 21, 2020.

Ircon International has signed a Memorandum of Understanding (MoU) with RZD International LLC, a subsidiary of state-owned Russian Railways Company to explore opportunities for joint development of railways and other infrastructure projects in Asia, Africa and Latin America. According to MoU, both parties have agreed to form a joint Indian - Russian working group. This group will look into ways of developing strong partnership to coordinate, plan and subsequently implement projects in field of railways and other infrastructure not only in India but also in countries of mutual interest.

Ashok Leyland’s board panel has approved the issuance of listed, secured, redeemable, non-convertible debentures (NCDs) with an aggregate amount up to Rs 300 crore with a green-shoe option of Rs 200 crore on private placement basis, in one or more tranches. The NCDs will be issued to certain eligible investors permitted to invest in the NCDs under applicable laws and will be listed on the National Stock Exchange. 

Intellect Design Arena has introduced iTurmeric FinCloud – its future-ready, cloud-ready, API-first, microservices-based platform – available today on IBM public cloud, the industry’s most secure and open public cloud for business.  Additionally, the company is one of the first financial services ISVs onboarding their offerings to the financial services-ready public cloud, once available, to provide its powerful industry solutions to leading financial institutions around the world, while addressing security and compliance readiness, and resiliency.

Torrent Pharmaceuticals has issued Non-Convertible Debentures (NCDs) on Private Placement basis for an amount of Rs 200 crore on May 14, 2020. The tenure of the instrument is 1072 days and will mature on April 21, 2023.

Godrej Consumer Products (GCPL) is betting big on its hygiene products range amid the COVID-19 crisis and plans to build the category as its ‘new core’ in the next two to three years. GCPL has planned several launches at affordable price points, most of which would be in personal and home care category, in the next 45 days. It expects hygiene products to account for around 5 per cent of its total business in this quarter alone as compared to very insignificant contribution in pre-COVID-19 period.

Everest Industries has resumed limited operations at the Company’s Kolkata Plant (West Bengal) and Podanur Plant (Tamil Nadu) after obtaining necessary approvals/permissions from the concerned government authorities.

Unichem Laboratories has received the Establishment Inspection..
Financials More
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit29809390
Gross Profit 3700 11170
Operating Profit 617021540
Net Sales 1727061680
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Alkem Laboratories (BSE)
 2831.10 (3.22%)
M.Cap ( in Cr)
33850.05
Advanced Enzyme (BSE)
 272.80 (19.99%)
M.Cap ( in Cr)
3046.59
Hester Biosciences (BSE)
 1747.10 (1.13%)
M.Cap ( in Cr)
1486.23
Alembic Pharma (BSE)
 934.35 (2.04%)
M.Cap ( in Cr)
18365.88
Panacea Biotec (BSE)
 196.80 (4.99%)
M.Cap ( in Cr)
1205.41
Shareholding Pattern More
NON-INSTITUTION 8.05 %
PROMOTERS 71.25 %
MUTUAL FUNDS/UTI 7.62 %
FI/BANKS/INSURANCE 0.02 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes